University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells

Fahey, CE, Milner, RJ, Kow, K, Bacon, NJ and Salute, ME (2013) Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells ANTI-CANCER DRUGS, 24 (5). pp. 519-526.

Full text not available from this repository.
Item Type: Article
Authors :
NameEmailORCID
Fahey, CEUNSPECIFIEDUNSPECIFIED
Milner, RJUNSPECIFIEDUNSPECIFIED
Kow, KUNSPECIFIEDUNSPECIFIED
Bacon, NJn.bacon@surrey.ac.ukUNSPECIFIED
Salute, MEUNSPECIFIEDUNSPECIFIED
Date : 1 June 2013
Identification Number : 10.1097/CAD.0b013e32836002ba
Uncontrolled Keywords : Science & Technology, Life Sciences & Biomedicine, Oncology, Pharmacology & Pharmacy, ONCOLOGY, PHARMACOLOGY & PHARMACY, canine osteosarcoma, comparative oncology, masitinib mesylate, tyrosine kinase inhibitor, DOXORUBICIN COMBINATION CHEMOTHERAPY, SIGNAL-TRANSDUCTION INHIBITION, APPENDICULAR OSTEOSARCOMA, GROWTH-FACTOR, IN-VITRO, OSTEO-SARCOMA, NUDE-MICE, DOGS, AMPUTATION, CISPLATIN
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:19
Last Modified : 17 May 2017 14:48
URI: http://epubs.surrey.ac.uk/id/eprint/827305

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800